Recent

% | $
Quotes you view appear here for quick access.

Myrexis, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • jacosa jacosa May 19, 2011 4:35 PM Flag

    ASCO abstract

    What I'm saying is that A business is in the bag, but to develop a WORTHWHILE business, they have to do testing to broaden the eligible patient population. The reported results would probably be enough to take much of the GBM salvage treatment market away from Avastin, but they aren't dramatic enough to get fast-track approval.

    One sincerely hopes that there will be an investigator-sponsored phase 2 combining Azixa with Avastin.

    You still ought to be in index funds, or closed-ends at the riskiest; not a little drug developer.

 
MYRX
0.14910.0000(0.00%)Jun 30 3:59 PMEDT